JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BRW
1701
Saba Capital Income & Opportunities Fund
BRW
$303M
| $15.4M | ﹤0.01% |
1,621,897
| – | – |
2013 Q2
24 quarters
|
|
|
XLNX
1702
PUT
DELISTED
Xilinx Inc
XLNX
| $15.4M | ﹤0.01% |
130,100
+110,400
| +560% | +$12.9M |
2019 Q1
1 quarter
|
|
1703
PUT
Regeneron Pharmaceuticals
REGN
$74.8B
| $15.3M | ﹤0.01% |
49,400
+10,300
| +26% | +$3.43M |
2017 Q1
9 quarters
|
|
1704
Bloomin' Brands
BLMN
$709M
| $15.3M | ﹤0.01% |
815,182
-89,996
| -10% | -$1.76M |
2014 Q4
18 quarters
|
|
1705
Adaptive Biotechnologies
ADPT
$4.76B
| $15.3M | ﹤0.01% |
+380,228
| New | +$16.8M |
2019 Q2
0 quarters
|
|
1706
Cedar Fair
FUN
$1.24B
| $15.3M | ﹤0.01% |
332,824
-67,770
| -17% | -$3.51M |
2013 Q2
24 quarters
|
|
1707
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.1B
| $15.3M | ﹤0.01% |
165,800
-100
| -0.1% | -$8.99K |
2016 Q4
10 quarters
|
|
1708
Comfort Systems
FIX
$60.3B
| $15.3M | ﹤0.01% |
302,004
+46,268
| +18% | +$2.38M |
2013 Q2
24 quarters
|
|
1709
CALL
Alnylam Pharmaceuticals
ALNY
$29.4B
| $15.3M | ﹤0.01% |
+215,000
| New | +$16.5M |
2019 Q2
0 quarters
|
|
1710
Fortive
FTV
$17.3B
| $15.3M | ﹤0.01% |
301,368
-1,459,768
| -83% | -$75.8M |
2016 Q3
11 quarters
|
|
1711
Old Republic International
ORI
$9.12B
| $15.2M | ﹤0.01% |
682,198
-104,327
| -13% | -$2.3M |
2013 Q2
24 quarters
|
|
1712
CALL
CSX Corp
CSX
$87.9B
| $15.2M | ﹤0.01% |
595,200
+566,400
| +1,967% | +$14.6M |
2019 Q1
1 quarter
|
|
|
INST
1713
DELISTED
Instructure, Inc.
INST
| $15.2M | ﹤0.01% |
364,342
-1,030,842
| -74% | -$44.5M |
2015 Q4
14 quarters
|
|
1714
Home BancShares
HOMB
$5.72B
| $15.1M | ﹤0.01% |
791,438
+579,205
| +273% | +$10.8M |
2013 Q2
24 quarters
|
|
|
CWEN.A
1715
DELISTED
Clearway Energy Class A
CWEN.A
| $15.1M | ﹤0.01% |
936,620
+8,486
| +0.9% | +$129K |
2015 Q2
16 quarters
|
|
1716
Gen Digital
GEN
$13.3B
| $15.1M | ﹤0.01% |
716,348
-755,920
| -51% | -$16.2M |
2013 Q2
24 quarters
|
|
1717
MYR Group
MYRG
$4.71B
| $15.1M | ﹤0.01% |
411,973
-809
| -0.2% | -$28.2K |
2016 Q3
11 quarters
|
|
|
WAGE
1718
DELISTED
WageWorks, Inc.
WAGE
| $15.1M | ﹤0.01% |
296,288
-118,085
| -28% | -$5.58M |
2013 Q2
24 quarters
|
|
|
SWAV
1719
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $15M | ﹤0.01% |
273,346
-57,466
| -17% | -$2.79M |
2019 Q1
1 quarter
|
|
1720
PUT
ConocoPhillips
COP
$154B
| $15M | ﹤0.01% |
244,900
| – | – |
2018 Q4
2 quarters
|
|
1721
PUT
Medtronic
MDT
$113B
| $15M | ﹤0.01% |
153,900
| – | – |
2017 Q2
8 quarters
|
|
|
DNKN
1722
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $15M | ﹤0.01% |
188,157
-642,249
| -77% | -$48.8M |
2013 Q2
24 quarters
|
|
1723
iShares MSCI Saudi Arabia ETF
KSA
$590M
| $15M | ﹤0.01% |
452,406
+451,506
| +50,167% | +$15.2M |
2019 Q1
1 quarter
|
|
1724
CALL
Abbott
ABT
$173B
| $15M | ﹤0.01% |
178,900
+155,700
| +671% | +$12.3M |
2017 Q2
8 quarters
|
|
1725
CALL
Honeywell
HON
$67.9B
| $14.9M | ﹤0.01% |
91,246
+50,928
| +126% | +$8.1M |
2016 Q2
12 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.